NO20090196L - Industriell prosess for syntese av 17α-acetoksy-11β-[4-(N,N-dimetyl-amino)-fenyl]-19-norpregna-4,9-dien-3,20-dion og nye mellomprodukter for prosessen - Google Patents

Industriell prosess for syntese av 17α-acetoksy-11β-[4-(N,N-dimetyl-amino)-fenyl]-19-norpregna-4,9-dien-3,20-dion og nye mellomprodukter for prosessen

Info

Publication number
NO20090196L
NO20090196L NO20090196A NO20090196A NO20090196L NO 20090196 L NO20090196 L NO 20090196L NO 20090196 A NO20090196 A NO 20090196A NO 20090196 A NO20090196 A NO 20090196A NO 20090196 L NO20090196 L NO 20090196L
Authority
NO
Norway
Prior art keywords
norpregna
formula
ethylenedioxy
reacted
diene
Prior art date
Application number
NO20090196A
Other languages
English (en)
Other versions
NO341620B1 (no
Inventor
Zoltan Tuba
Lajosne Dancsi
Gyorgy Visky
Janos Csorgei
Csaba Molnar
Endrene Magyari
Original Assignee
Richter Gedeon Nyrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Nyrt filed Critical Richter Gedeon Nyrt
Publication of NO20090196L publication Critical patent/NO20090196L/no
Publication of NO341620B1 publication Critical patent/NO341620B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Foreliggende oppfinnelse angår en ny industriell fremgangsmåte for syntese av solvatfritt 17a-acet-oksy-lip-[4-(N,N-dimetylamino)-fenyl]-19-norpregna-4, 9-dien-3,20-dion [CDB-2914] av formel (I) som er et sterkt antiprogestogent og antiglukokortikoid middel. Oppfinnelsen angår også forbindelser av formel (VII) og (VIII) anvendt som mellomprodukter i prosessen. Fremgangsmåten ifølge oppfinnelsen er følgende: i) 3-(etylendioksy)-østra-5(10),9(11)-dien-17-on av formel (X) omsettes med kalium-acetilyd dannet in situ i tørt tetrahydrofuran på kjent måte, ii) det erholdte 3- (etylendioksy)-17<x-etynyl-17p-hydroksy-østra-5(10),9(11)-dien av formel (IX) omsettes med fenylsulfenylklorid i diklormetan i nærvær av trietyl-amin og eddiksyre, iii) den erholdte isomere blanding av 3-(etylendioksy)-21-(fenylsulfinyl)-19-norpregna- 5 (10), 9(11), 17(20), 20-tetraen av formel (VIII) omsettes først med natriummetoksid i metanol, deretter med trimetylfosfitt, iv) det erholdte 3-(etylendioksy)-17a-hydroksy-2 0-metoksy-19-norpregna-5(10),9(11),20-trien av formel (VII) omsettes med hydrogenklorid
NO20090196A 2006-06-14 2009-01-13 Industriell fremgangsmåte for syntese av 17-acetoksy-11-[4-(N,N-dimetylamino)-fenyl]-19-norpregna-4,9-dien-3,20-dion og nye mellomprodukter for prosessen NO341620B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0600491A HU227112B1 (hu) 2006-06-14 2006-06-14 Ipari eljárás 17-alfa-acetoxi-11-béta-[4-(N,N-dimetil-amino)-fenil]-19-norpregna-4,9-dién-3,20-dion elõállítására és új intermedierek az eljáráshoz
PCT/HU2007/000045 WO2007144674A1 (en) 2006-06-14 2007-05-18 INDUSTRIAL PROCESS FOR THE SYNTHESIS OF 17α-ACETOXY-11β-[4-(N,N-DIMETHYL-AMINO)- PHENYL]-19-NORPREGNA-4,9-DIENE-3,20-DIONE AND NEW INTERMEDIATES OF THE PROCESS

Publications (2)

Publication Number Publication Date
NO20090196L true NO20090196L (no) 2009-03-10
NO341620B1 NO341620B1 (no) 2017-12-11

Family

ID=89986843

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20090196A NO341620B1 (no) 2006-06-14 2009-01-13 Industriell fremgangsmåte for syntese av 17-acetoksy-11-[4-(N,N-dimetylamino)-fenyl]-19-norpregna-4,9-dien-3,20-dion og nye mellomprodukter for prosessen

Country Status (22)

Country Link
US (1) US8110691B2 (no)
EP (1) EP2027140B1 (no)
JP (1) JP5274453B2 (no)
CN (1) CN101466723B (no)
AR (1) AR061052A1 (no)
AU (1) AU2007258955B2 (no)
BR (1) BRPI0713157A2 (no)
CA (1) CA2653552C (no)
DK (1) DK2027140T3 (no)
EA (1) EA015302B1 (no)
ES (1) ES2409841T3 (no)
HU (1) HU227112B1 (no)
IL (1) IL195253A (no)
MX (1) MX2008015972A (no)
NO (1) NO341620B1 (no)
PL (1) PL2027140T3 (no)
PT (1) PT2027140E (no)
RS (1) RS52758B (no)
SI (1) SI2027140T1 (no)
UA (1) UA94269C2 (no)
WO (1) WO2007144674A1 (no)
ZA (1) ZA200809799B (no)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102241722B (zh) * 2010-05-12 2015-11-25 杭州容立医药科技有限公司 一种合成孕酮受体调节剂优力司特的纯化方法
CN102372760A (zh) * 2010-08-12 2012-03-14 杭州容立医药科技有限公司 一种合成孕酮受体调节剂优力司特的合成方法
CN102477060B (zh) * 2010-11-22 2014-08-13 华润紫竹药业有限公司 甾体化合物及其制备方法和用途
CN102516345B (zh) 2011-11-01 2014-11-26 上海优拓医药科技有限公司 醋酸乌利司他及其关键中间体的制备方法
CN102295674B (zh) * 2011-07-14 2013-04-10 四川大学 获得高纯度17α-乙酰氧基-11β-（4-N,N-二甲氨基苯基）-19-去甲孕甾-4,9-二烯-3,20-二酮的方法
CN102321141B (zh) * 2011-07-22 2013-05-15 上海希迈医药科技有限公司 一种17α-乙酰氧基-11β-（4-N,N-二甲氨基苯基）-19-去甲孕甾-4，9-二烯-3,20-二酮的无定形物及其制备方法
CN102344478B (zh) * 2011-07-22 2013-08-07 上海希迈医药科技有限公司 一种17α-乙酰氧基-11β-(4-N,N-二甲氨基苯基)-19-去甲孕甾-4,9-二烯-3,20-二酮的结晶物及其制备方法
CN103193850A (zh) * 2012-01-04 2013-07-10 北京紫竹药业有限公司 甾体化合物的新晶型及其制备方法
CN104628806A (zh) * 2012-01-19 2015-05-20 华润紫竹药业有限公司 甾体化合物及其制备方法和用途
CN106046099B (zh) * 2012-01-19 2018-03-16 华润紫竹药业有限公司 甾体化合物及其制备方法和用途
CN102675395B (zh) * 2012-04-17 2014-04-30 常州市第四制药厂有限公司 醋酸乌利司他的多晶型及其制备方法
CN103755765B (zh) * 2012-04-17 2018-01-02 常州市第四制药厂有限公司 醋酸乌利司他的多晶型及其制备方法
CN102702296B (zh) * 2012-06-19 2014-09-03 山东诚创医药技术开发有限公司 环-3,20-双(1,2-亚乙基缩醛)-17α-羟基-17β-乙酰基-雌甾-5(10),9(11)-二烯-3-酮的制备方法
WO2014050107A1 (en) * 2012-09-28 2014-04-03 Aska Pharmaceutical Co., Ltd. Crystalline polymorphic form of ulipristal acetate
AU2013321890B2 (en) 2012-09-28 2017-05-18 Aska Pharmaceutical Co., Ltd. Crystalline polymorphic form of ulipristal acetate
WO2014050105A1 (en) 2012-09-28 2014-04-03 Aska Pharmaceutical Co., Ltd. Amorphous ulipristal acetate
CN102875629B (zh) * 2012-10-10 2014-11-19 苏州康润医药有限公司 醋酸乌利司他的合成方法
WO2014060888A1 (en) * 2012-10-18 2014-04-24 Lupin Limited Novel process and intermediate for preparation of ulipristal
CN102942612A (zh) * 2012-10-30 2013-02-27 四川大学 一种合成醋酸乌利司他的新方法
CN103804456B (zh) * 2012-11-15 2017-08-04 上海创诺医药集团有限公司 醋酸乌利司他中间体及其制备方法
CN103145787B (zh) * 2012-12-25 2017-02-22 常州市亚邦医药研究所有限公司 制备醋酸优力司特关键中间体的新方法
CN103087140A (zh) * 2013-03-04 2013-05-08 四川尚锐生物医药有限公司 一种醋酸优力司特多晶型的制备方法
CN103145788B (zh) * 2013-03-25 2015-08-19 浙江仙琚制药股份有限公司 醋酸优力司特关键中间体的制备方法
HU230319B1 (hu) 2013-10-01 2016-01-28 Richter Gedeon Nyrt. Ipari eljárás szteroid hatóanyagok előállítására
CN103755763A (zh) * 2013-12-30 2014-04-30 烟台东诚生化股份有限公司 17α-乙酰氧基-11β-[4-(N,N-二甲基氨基)-苯基]-19-去甲孕甾-4,9-二烯-3,20-二酮的制备方法
CN104530169B (zh) * 2014-12-12 2017-09-12 成都化润药业有限公司 一种醋酸乌利司他及其中间体的制备方法
CN106986908B (zh) * 2017-03-23 2019-05-10 湖南玉新药业有限公司 倍他米松的制备方法
CN106986911B (zh) * 2017-03-23 2019-05-10 湖南玉新药业有限公司 地塞米松关键中间体联烯亚砜物的制备方法
CN108558982A (zh) * 2018-05-21 2018-09-21 郑州泰丰制药有限公司 一种新型醋酸乌利司他以及其生产制造方法
CN109053846B (zh) * 2018-08-14 2020-01-07 台州仙琚药业有限公司 制备醋酸优力司特双缩酮的方法
CN111349137A (zh) * 2018-12-21 2020-06-30 北京启慧生物医药有限公司 一种绿色合成醋酸乌利司他中间体及醋酸乌利司他的方法
CN110256519B (zh) * 2019-05-23 2021-06-08 江苏联环药业股份有限公司 一锅法制备醋酸乌利司他的方法
CN119490551B (zh) * 2024-11-15 2025-10-31 湖北葛店人福药业有限责任公司 一种地屈孕酮的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4041055A (en) * 1975-11-17 1977-08-09 The Upjohn Company Process for the preparation of 17α-hydroxyprogesterones and corticoids from androstenes
US4954490A (en) 1988-06-23 1990-09-04 Research Triangle Institute 11 β-substituted progesterone analogs
US5929262A (en) * 1995-03-30 1999-07-27 The United States Of America As Represented By The Department Of Health And Human Services Method for preparing 17α-acetoxy-11β-(4-N, N-dimethylaminophyl)-19-Norpregna-4,9-diene-3, 20-dione, intermediates useful in the method, and methods for the preparation of such intermediates
AU775831B2 (en) * 1999-12-29 2004-08-19 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Process for preparing 17alpha-acetoxy-11beta-(4-N,N-(dimethylamino)phenyl)-21- methoxy-19-norpregna-4,9-diene-3,20-dione, intermediates useful in the process, and processes for preparing such intermediates
US6512130B1 (en) * 2000-09-05 2003-01-28 Council Of Scientific And Industrial Research Mifepristone analogue, process for the preparation thereof and use thereof
AU2004217988C1 (en) * 2003-02-28 2010-06-03 Southwest Foundation For Biomedical Research Method for preparing 17 alpha-acetoxy-11beta-(4-N,N-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione, intermediates thereof, and methods for the preparation of such intermediates
FR2854403B1 (fr) * 2003-04-29 2008-07-11 Aventis Pharma Sa Nouveau procede et intermediaires de preparation de composes 19-nor-steroides 17-halogenes
HUP0301332A3 (en) * 2003-05-14 2006-04-28 Richter Gedeon Vegyeszet New mono-and bismethylene steroid derivatives and process for their synthesis and pharmaceutical compositions containing them
ITMI20042001A1 (it) * 2004-10-21 2005-01-21 Ind Chimica Srl Processo per la preparazione di 21-idrossi steroidi con controllo della distribuzione epimerica nella posizione c-21

Also Published As

Publication number Publication date
CN101466723B (zh) 2011-11-02
SI2027140T1 (sl) 2013-07-31
DK2027140T3 (da) 2013-06-03
CA2653552A1 (en) 2007-12-21
IL195253A (en) 2011-11-30
JP2009539964A (ja) 2009-11-19
US20090187032A1 (en) 2009-07-23
CN101466723A (zh) 2009-06-24
EA015302B1 (ru) 2011-06-30
UA94269C2 (en) 2011-04-26
EP2027140B1 (en) 2013-03-13
IL195253A0 (en) 2009-08-03
MX2008015972A (es) 2009-01-12
HUP0600491A2 (en) 2008-02-28
WO2007144674A1 (en) 2007-12-21
ES2409841T3 (es) 2013-06-28
AU2007258955B2 (en) 2012-09-20
ZA200809799B (en) 2009-11-25
EA200900015A1 (ru) 2009-04-28
PT2027140E (pt) 2013-06-04
EP2027140A1 (en) 2009-02-25
AR061052A1 (es) 2008-07-30
JP5274453B2 (ja) 2013-08-28
US8110691B2 (en) 2012-02-07
BRPI0713157A2 (pt) 2012-04-03
HU227112B1 (hu) 2010-07-28
RS52758B (sr) 2013-08-30
NO341620B1 (no) 2017-12-11
PL2027140T3 (pl) 2013-09-30
CA2653552C (en) 2013-04-23
HU0600491D0 (en) 2006-08-28
AU2007258955A1 (en) 2007-12-21

Similar Documents

Publication Publication Date Title
NO20090196L (no) Industriell prosess for syntese av 17α-acetoksy-11β-[4-(N,N-dimetyl-amino)-fenyl]-19-norpregna-4,9-dien-3,20-dion og nye mellomprodukter for prosessen
JP5260537B2 (ja) プロゲステロンレセプターアンタゴニスト
FI85377B (fi) Foerfarande foer framstaellning av terapeutiskt aktiva 13-alkyl-11 -fenylgonaner.
RU2152952C2 (ru) Производные 11,21-бисфенил-19-норпрегнана, способ их получения, фармацевтическая композиция и способ ее получения
EA200802385A1 (ru) КРИСТАЛЛИЧЕСКИЕ ФОРМЫ 11β-(4-АЦЕТИЛФЕНИЛ)-20,20,21,21,21-ПЕНТАФТОР-17-ГИДРОКСИ-19-НОР-17A-ПРЕГНА-4,9-ДИЕН-3-ОНА
SK15692002A3 (sk) 3-Amino-6,7-dioxygénované steroidy a s nimi súvisiace použitie
AU2004200263A1 (en) Pharmaceutical compounds
BR112014010263B1 (pt) Método de preparação do acetato de ulipristal e intermediário deste
FI94349B (fi) Menetelmä terapeuttisesti aktiivisten 11 -fenyyli-4,9,15-estratrieenien valmistamiseksi
AR067189A1 (es) Metodo industrial para la sintesis de 17-acetoxi-11beta-(4-(dimetilamino)-fenil)-21-metoxi-19-norpregna-4,9-dien-3,20-diona y los intermediarios claves del proceso
IE67514B1 (en) 11beta-phenyl-14betaH steroids
PT825197E (pt) Novos derivados de 6-hidroxi e 6-oxo-androstano com actividade sobre o sistema cardiovascular e composicoes farmaceuticas que os contem
BR0111058A (pt) Formas de sólidos de 11 beta-[4e-(hidroxiiminometil)-fenil]-17 alfa-metoximetil-17 beta-metóxi-estra-4,9-dien-3-ona de mesoprogestina
US5336686A (en) 17 Methylene lactones of steroids
Glover et al. The HERON reaction Origin, theoretical background, and prevalence
AU642757B2 (en) 4-amino-delta4, 6-steroids and their use as 5alpha-reductase inhibitors
Zhou et al. Study on synthesis of key squalamine intermediate 7α, 24R-dihydroxy-5α-cholestan-3-one
Dittrich et al. Traceless bond construction via rearrangement of N-Boc-N-allylhydrazones giving 1, 1-disubstituted olefins
Bansal et al. Synthesis and Antineoplastic Activity of O‐Alkylated Derivatives of 7‐Hydroximinoandrost‐5‐ene Steroids
US5189032A (en) 4-amino-Δ4,6 -steroids and their use as 5α-reductase inhibitors
KR0184643B1 (ko) 4-아미노-델타4,6-스테로이드 및 5알파-환원효소 억제제로서의 그의 용도
JPH0912593A (ja) 心臓血管系に活性な新規１７−ヒドロキシイミノアルキルおよび１７−ヒドロキシイミノメチルアルケニルシクロペンタンペルヒドロフェナントレン誘導体、それらの製造方法およびそれらの化合物を含む医薬組成物
BRPI0720206A2 (pt) Processo para a obtenção diastereosseletiva de uma amina primária quiral sobre um esteróide.
JPH06211893A (ja) 心臓血管系に活性を有する新規シクロペンタンペルヒドロフェナントレン−１７β−（ヒドロキシまたはアルコキシ）−１７α−（アリールまたはヘテロシクリル）−３β−誘導体、その製法、およびこれを含む薬学的組成物
CN1908003A (zh) 9α－溴－11β－羟基孕甾－1,4,16－三烯－3,20－二酮合成法

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees